Oxaliplatin - Global Comprehensive Analysis of Industry Dynamics and Market Sales Trends 2024

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

The global Oxaliplatin market size is expected to reach US$ 1641.5 million by 2029, growing at a CAGR of 8.9% from 2023 to 2029. The market is mainly driven by the significant applications of Oxaliplatin in various end use industries. The expanding demands from the Colorectal Cancer, Stomach Cancer, Ovarian Cancer and Others, are propelling Oxaliplatin market. Mannitol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glucose Solution segment is estimated at % CAGR for the next seven-year period.

Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oxaliplatin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Oxaliplatin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Oxaliplatin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oxaliplatin sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Oxaliplatin covered in this report include Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan and Jiangsu Hengrui Medicine, etc.

The global Oxaliplatin market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Sanofi-Aventis

Yakult honsha

Dr Reddy's laboratories

Sun Pharmaceutical

Teva

Fresenius Kabi

Hospira

Mylan

Jiangsu Hengrui Medicine

Nanjing Pharmaceutical Factory

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Hisun Pharmaceutical

Lunan Pharmaceutical

Luoxin

Halfsky Pharmacy

YRPG

Hainan Jinrui Pharmaceutical

Jari Pharmaceutical

Chiatai Tianqing

Global Oxaliplatin market, by region:

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Oxaliplatin market, Segment by Type:

Mannitol

Glucose Solution

Lactose Solution

Others

Global Oxaliplatin market, by Application

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of Oxaliplatin companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion